588 results on '"James, Stefan"'
Search Results
2. Patients’ experiences of clinical trial participation involving a product remotely assessing study drug adherence
3. Left atrial dysfunction in bicuspid aortic valve patients with severe aortic stenosis is associated with postoperative atrial fibrillation following aortic valve replacement
4. Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
5. Characteristics and Outcomes of Patients Receiving a Second Rescue Valve During Transcatheter Aortic Valve Implantation
6. A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
7. European Society of Cardiology Quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation
8. Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
9. Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
10. Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
11. Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
12. Improved patient care starts with data collection
13. External validation of the Netherlands Heart Registration (NHR) prediction model for early mortality after transcatheter aortic valve implantation (TAVI)
14. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials
15. ST-segment elevation myocardial infarction
16. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study
17. Effects of pharmacological interventions on short- and long-term mortality in patients with takotsubo syndrome: a report from the SWEDEHEART registry
18. Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies
19. Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
20. Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
21. Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review
22. Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials
23. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
24. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum]
25. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
26. Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS
27. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
28. The Remote Exercise SWEDEHEART study – Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)
29. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
30. Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation
31. Is the TIME study on antihypertensive therapy and chronotropic effects on cardiovascular outcomes a pragmatic trial?
32. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
33. Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease
34. Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome
35. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
36. Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency
37. Reply
38. Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
39. Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR
40. Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation
41. Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
42. Introduction
43. ST-segment elevation MI
44. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register
45. 518 DUAL ANTIPLATELET THERAPY DE-ESCALATION MODALITIES IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
46. 532 SEX-RELATED DIFFERENCES IN THROMBUS BURDEN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
47. Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial
48. Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Substudy of VALIDATE-SWEDEHEART Trial
49. On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography Study
50. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.